Biological effects of a maternal ED on pregnancy and foetal development: a review

Nadia Micali1, Janet Treasure

  • 1Child & Adolescent Psychiatry, Institute of Psychiatry, King's College London, London, UK. N.Micali@iop.kcl.ac.uk

Insights

Maternal eating disorders (EDs) during pregnancy can significantly impact fetal development, potentially leading to long-term health issues for the child. This review highlights biological risk mechanisms requiring further investigation.

Area of Science:

  • Reproductive Biology
  • Developmental Psychology
  • Clinical Nutrition

Background:

  • Maternal eating disorders (EDs) during pregnancy present complex challenges for both mother and fetus.
  • Comorbidities associated with EDs can further complicate perinatal outcomes.
  • Understanding the biological impact on the fetus is crucial for long-term offspring health.

Purpose of the Study:

  • To review existing literature on the biological effects of maternal EDs on the fetus.
  • To identify potential risk mechanisms for long-term consequences in offspring.
  • To propose a developmental model for these adverse outcomes.

Main Methods:

  • Comprehensive literature search using PubMed, PsychInfo, and Google Scholar.
  • Manual review of relevant research papers.
  • Synthesis of findings on EDs, psychopathology, and perinatal outcomes.

Main Results:

  • Maternal EDs during pregnancy are associated with significant biological effects on the fetus.
  • Potential risk mechanisms for long-term nutritional and psychopathological outcomes in offspring were identified.
  • A developmental model illustrating these risks was proposed.

Conclusions:

  • Maternal EDs during pregnancy likely exert important long-term biological influences on fetal development.
  • Further research is essential to elucidate the specific biological risk mechanisms involved.
  • Clarifying these mechanisms can inform interventions to mitigate long-term risks for offspring.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Nondisjunction01:21

Nondisjunction

Nondisjunction is the failure of homologous chromosomes or sister chromatids to separate correctly and move to the opposite poles of the cells. This produces daughter cells with abnormal chromosome numbers.  Nondisjunction is common during anaphase I or anaphase II of meiosis.  Mutations in synaptonemal complex proteins that attach homologous chromosomes increase the chances of nondisjunction in anaphase I of meiosis I. In contrast, mutations in topoisomerases and condensins that hold sister...